Madison Muller

Stay informed with Madison Muller’s coverage and analysis.

Page 2 of 3

  • Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty ImagesHealth

    North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030

    By Simone Foxman, Madison Muller, and others
  • Weight loss drugs are all the rage.Health

    Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro

    By Madison Muller and Bloomberg
  • Wegovy, an injectable prescription weight-loss medicine.Health

    A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’

    By Madison Muller, Naomi Kresge, and others
  • David Ricks, chairman and chief executive officer of Eli Lilly & Co., speaks during a Senate Health, Education, Labor, and Pensions Committee hearing in Washington, DC, US, on Wednesday, May 10, 2023. The hearing is titled The Need to Make Insulin Affordable for All Americans. Photographer: Al Drago/Bloomberg via Getty ImagesHealth

    FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy

    By Madison Muller and Bloomberg
  • Jacksonville, FL – August 25: Ashley Dunham preps for her weekly dosage of Ozempic. (Malcom Jackson for The Washington Post via Getty Images)Health

    Weight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds

    By Madison Muller and Bloomberg
  • Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company’s headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Carsten Snejbjerg/Bloomberg via Getty ImagesHealth

    Weight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say

    By Madison Muller and Bloomberg
  • An Ozempic needle injection pen is seen in this illustration photo in Warsaw, Poland on 03 September, 2023. (Photo by Jaap Arriens/NurPhoto via Getty Images)Health

    Some weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’

    By Madison Muller and Bloomberg
  • Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk, speaks during an interview in New York, US, on Wednesday, Aug. 10, 2022. Two more factories will begin producing Novo Nordisk A/S’s obesity medication Wegovy next year after manufacturing issues and high demand left the drug in short supply, Jorgensen said. Photographer: Christopher Goodney/Bloomberg via Getty ImagesHealth

    Yet another weight loss drug is now hard to get as high demand creates major shortages

    By Emma Court, Madison Muller, and others
  • HOUSTON, TEXAS – JULY 08: The Reyes family wait to receive baby formula in a Walmart Supercenter on July 08, 2022 in Houston, Texas. Consumer goods continue seeing shortages as the country grapples with ongoing supply chain issues stemming from the pandemic. (Photo by Brandon Bell/Getty Images)Retail

    Baby formula prices just soared to an all-time high and manufacturers are blaming it on new regulations that ‘significantly’ raise their costs

    By Augusta Saraiva, Madison Muller, and others
  • JAKARTA, INDONESIA – JANUARY 25: A health officer injects a second COVID-19 vaccine booster to a resident at the courtyard of the Jakarta Governor’s office in Jakarta, Indonesia on January 25, 2023. Indonesian Ministry of Health is set to start administering the second COVID-19 vaccine booster for the public on Tuesday, January 24, 2023, as an effort to accelerate vaccination while increasing protection against the virus. (Photo by Eko Siswono Toyudho/Anadolu Agency via Getty Images)Health

    Seniors and people with weakened immune systems can now get a second Omicron booster as new COVID subvariants emerge

    By Madison Muller, Fiona Rutherford, and others
  • Hong Kong departures

    The whole world is watching to see if any new COVID variant comes out of China

    By Madison Muller and Bloomberg
  • China airlineHealth

    Every passenger from China will have to test negative to enter the U.S.

    By Madison Muller and Bloomberg
  • Impella patientHealth

    Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood

    By Madison Muller and Bloomberg
  • MonkeypoxHealth

    Monkeypox may have just claimed its first victim in the U.S., Texas officials say

    By Madison Muller and Bloomberg
  • Beyonce, a rescue Beagle.Health

    Pets suspected of having monkeypox should be isolated, CDC says

    By Madison Muller and Bloomberg